Arias-Salgado, E.G.; Álvarez Román, M.T.; Dos Santos Ortas, A.; Fernandéz-Bello, I.; Monzón Manzano, E.; Acuña, P.; Martín Salces, M.; Rivas Pollmar, M.I.; García Barcenilla, S.; Butta, N.V.;
et al. Procoagulant Effect of FIX Concentrates and Bypass Agents in Combination with Emicizumab and Impact of FVIII Inhibitors. Biomedicines 2026, 14, 777.
https://doi.org/10.3390/biomedicines14040777
AMA Style
Arias-Salgado EG, Álvarez Román MT, Dos Santos Ortas A, Fernandéz-Bello I, Monzón Manzano E, Acuña P, Martín Salces M, Rivas Pollmar MI, García Barcenilla S, Butta NV,
et al. Procoagulant Effect of FIX Concentrates and Bypass Agents in Combination with Emicizumab and Impact of FVIII Inhibitors. Biomedicines. 2026; 14(4):777.
https://doi.org/10.3390/biomedicines14040777
Chicago/Turabian Style
Arias-Salgado, Elena G., María Teresa Álvarez Román, Abel Dos Santos Ortas, Ihosvany Fernandéz-Bello, Elena Monzón Manzano, Paula Acuña, Mónica Martín Salces, Maria Isabel Rivas Pollmar, Sara García Barcenilla, Nora V. Butta,
and et al. 2026. "Procoagulant Effect of FIX Concentrates and Bypass Agents in Combination with Emicizumab and Impact of FVIII Inhibitors" Biomedicines 14, no. 4: 777.
https://doi.org/10.3390/biomedicines14040777
APA Style
Arias-Salgado, E. G., Álvarez Román, M. T., Dos Santos Ortas, A., Fernandéz-Bello, I., Monzón Manzano, E., Acuña, P., Martín Salces, M., Rivas Pollmar, M. I., García Barcenilla, S., Butta, N. V., & Jimenéz-Yuste, V.
(2026). Procoagulant Effect of FIX Concentrates and Bypass Agents in Combination with Emicizumab and Impact of FVIII Inhibitors. Biomedicines, 14(4), 777.
https://doi.org/10.3390/biomedicines14040777
